Companies

Eris Lifesciences Q1 standalone net up 6% to ₹87 crore

Our Bureau Ahmedabad | Updated on August 04, 2020 Published on August 04, 2020

Board declares 550% interim dividend

Eris Lifesciences Limited on Tuesday posted a standalone net profit of ₹87 crore for the first quarter ended June 2020, as against ₹82 crore recorded in the corresponding quarter a year ago, indicating 6 per cent year-on-year rise.

Its revenues from operations stood at ₹261 crore, as against ₹262 crore.

On consolidated basis, its net profit stood at ₹89 crore, which is about 6 per cent higher than ₹84 crore it recorded in the same quarter last year. The consolidated revenues from operations stood at ₹293 crore for the quarter as against ₹277 crore last year for same quarter.

The board of directors has declared interim dividend of ₹5.50 (at the rate of 550 per cent) on each fully paid-up equity share of ₹1 for the financial year 2020-21.

Company shares ended at ₹510 on Tuesday, down by nearly 6 per cent from previous close on the Bombay Stock Exchange.

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

Published on August 04, 2020
This article is closed for comments.
Please Email the Editor